We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
As filed with the Securities and Exchange Commission on March 8, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
falseFY000181771300018177132022-01-012022-12-310001817713us-gaap:ComputerEquipmentMember2022-12-310001817713us-gaap:AdditionalPaidInCapitalMember2021-12-310001817713us-gaap:FairValueInputsLevel3Mem...
false000181771300018177132024-03-082024-03-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
Recently presented positive Phase 1 clinical trial data for PSMA-TRACTr JANX007 in mCRPC and for EGFR-TRACTr JANX008 in solid tumors Enrollment ongoing for JANX007 and JANX008 Update on JANX007...
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-266720 PROSPECTUS SUPPLEMENT (to Prospectus dated September 19, 2022) 4,440,851 Shares of Common Stock...
0001817713false00018177132024-02-282024-02-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Dated February 28, 2024 Relating to Preliminary Prospectus Supplement Dated February 27, 2024 Registration Statement...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.5 | -6.22665006227 | 40.15 | 41.7199 | 36.935 | 377073 | 39.00621283 | CS |
4 | -14.35 | -27.5961538462 | 52 | 54.88 | 36.23 | 801695 | 43.1564624 | CS |
12 | 27.27 | 262.716763006 | 10.38 | 58.6936 | 7.79 | 742351 | 41.92335586 | CS |
26 | 27.66 | 276.876876877 | 9.99 | 58.6936 | 5.65 | 408910 | 36.65349932 | CS |
52 | 26.11 | 226.256499133 | 11.54 | 58.6936 | 5.65 | 257375 | 31.51483088 | CS |
156 | 3.65 | 10.7352941176 | 34 | 58.6936 | 5.65 | 167935 | 26.40452025 | CS |
260 | 3.65 | 10.7352941176 | 34 | 58.6936 | 5.65 | 167935 | 26.40452025 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions